Company / Depreciation & Amortization
PTC Therapeutics, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$38.8M
FY2025
5-year range
$32.2M / $236.6M
FY2021-FY2025
Trend
-48.7%
vs FY2024
Sector context
#34 of 163
Health Care
What the data says
PTC Therapeutics, Inc.'s depreciation & amortization of $39M is higher than 79% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $3M in FY2016 to $237M in FY2023.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of +8.3%. Top quartile in the Health Care sector.
Improved from $237M to $39M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -3.7%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -
Sector benchmark
-82.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.3%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 48.7% year-over-year.
- Ranks #34 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.8M | -48.7% |
| FY2024 | $75.7M | -68.0% |
| FY2023 | $236.6M | +444.0% |
| FY2022 | $43.5M | +35.1% |
| FY2021 | $32.2M | +23.4% |
| FY2020 | $26.1M | -18.9% |
| FY2019 | $32.2M | +23.4% |
| FY2018 | $26.1M | +47.5% |
| FY2017 | $17.7M | +437.4% |
| FY2016 | $3.3M | +14.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026